CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 698 of 698 entries

View as:

Systematic Evaluation of Continuous Glucose Monitoring Data

Phase: N/A Priority: Normal

NCT ID: NCT03545178 Org: User:

Start: 04/01/18 End: 07/19/19 Due: 07/19/20

Pharmacokinetic Study to Investigate the Bioavailability and Tolerability of 3 Oral Formulations of Sodium Thiosulfate

Phase: N/A Priority: Normal

NCT ID: NCT02624479 Org: User:

Start: 12/31/18 End: 12/31/19 Due: 12/31/20

Validation of High-resolution PET/CT for the Pretherapeutic Lymphnode Staging of Head/Neck Cancer

Phase: N/A Priority: Normal

NCT ID: NCT02372890 Org: User:

Start: 07/31/12 End: 12/31/17 Due: 12/31/18

The Ocular Microbiome in Patients With Dry Eye Disease

Phase: N/A Priority: Normal

NCT ID: NCT04656197 Org: User:

Start: 09/30/19 End: 03/04/20 Due: 03/04/21

Surgical Versus Non-Surgical Treatment of Thoracolumbar Burst Fracture

Phase: N/A Priority: Normal

NCT ID: NCT05769114 Org: User:

Start: 04/18/23 End: 03/31/30 Due: 03/31/31

Assessment of Anatomic, Physiologic and Biomechanical Characteristics of the Anal Canal and Pelvic Floor. An Observational Pilot Study

Phase: N/A Priority: Normal

NCT ID: NCT02263170 Org: User:

Start: 03/31/15 End: 11/30/15 Due: 11/30/16

Predicting Disease Activity and Rebound Risk in MS Patients Treated With Sphingosine-1-phosphate Receptor Modulators (S1PRM)

Phase: N/A Priority: Normal

NCT ID: NCT05828901 Org: User:

Start: 03/27/23 End: 03/31/27 Due: 03/31/28

Suprafascial Vancomycin Powder for Prevention of Surgical Site Infections After Instrumented Posterior Spinal Fusion

Phase: N/A Priority: Normal

NCT ID: NCT04017468 Org: User:

Start: 10/15/19 End: 03/31/27 Due: 03/31/28

Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease in Children With Cystic Fibrosis

Phase: N/A Priority: Normal

NCT ID: NCT04026360 Org: User:

Start: 07/01/11 End: 12/31/50 Due: 12/31/51

Status Telemetry for Cochlear Implantations

Phase: N/A Priority: Normal

NCT ID: NCT06223724 Org: User:

Start: 10/25/23 End: 10/01/24 Due: 10/01/25

Prophylactic Mesh Implantation in Patients With Peritonitis for the Prevention of Incisional Hernia

Phase: N/A Priority: Normal

NCT ID: NCT01802164 Org: User:

Start: 03/31/13 End: 04/30/15 Due: 04/30/16

Fetal Monitoring by Transabdominal Electrocardiogram Recording

Phase: N/A Priority: Normal

NCT ID: NCT04574739 Org: User:

Start: 07/01/20 End: 10/31/20 Due: 10/31/21

Artificial Intelligence (AI) in Cardiotocography (CTG) Interpretation

Phase: N/A Priority: Normal

NCT ID: NCT04584281 Org: User:

Start: 10/31/20 End: 06/30/21 Due: 06/30/22

MRI-markers to Monitor Small Vessel Disease Dynamics in the Prognosis of Small Vessel Disease-associated, Cerebrovascular Events

Phase: N/A Priority: Normal

NCT ID: NCT05773235 Org: User:

Start: 07/01/22 End: 06/30/24 Due: 06/30/25

Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment

Phase: N/A Priority: Normal

NCT ID: NCT02068625 Org: User:

Start: 09/30/10 End: 12/31/18 Due: 12/31/19

Stress Response in Emergency Among Physicians in Helicopter and Ambulance Based Emergency Medical Systems

Phase: N/A Priority: Normal

NCT ID: NCT03422952 Org: User:

Start: 04/30/17 End: 11/01/18 Due: 11/01/19

Bendamustine and Melphalan in Myeloma

Phase: N/A Priority: Normal

NCT ID: NCT03187223 Org: User:

Start: 07/20/17 End: 05/28/20 Due: 05/28/21

ILMA Fastrach Versus I-gel for Fiberoptic Tracheal Intubation

Phase: N/A Priority: Normal

NCT ID: NCT00888875 Org: User:

Start: 07/31/08 End: 05/31/10 Due: 05/31/11

Involvement of the Gut Microbiota in Calcified Aortic Stenosis

Phase: N/A Priority: Normal

NCT ID: NCT06021535 Org: User:

Start: 01/01/24 End: 12/31/28 Due: 12/31/29

Renal Denervation in Patients With Recurrent Atrial Fibrillation After Successful Pulmonary Vein Isolation

Phase: N/A Priority: Normal

NCT ID: NCT05817318 Org: User:

Start: 06/27/23 End: 12/31/26 Due: 12/31/27

Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis

Phase: N/A Priority: Normal

NCT ID: NCT04874428 Org: User:

Start: 05/19/21 End: 06/30/26 Due: 06/30/27

Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients

Phase: N/A Priority: Normal

NCT ID: NCT05636787 Org: User:

Start: 06/06/23 End: 04/30/28 Due: 04/30/29

Visual Field Defect Estimation Using Sequentially Optimized Reconstruction Strategy on Healthy and Glaucoma Subjects

Phase: N/A Priority: Normal

NCT ID: NCT03325751 Org: User:

Start: 06/01/18 End: 11/01/19 Due: 11/01/20

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Systematic Evaluation of Continuous Glucose Monitoring Data	NCT03545178	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2018-04-01	2019-07-19	2020-07-19	-	-	2025-07-14
Pharmacokinetic Study to Investigate the Bioavailability and Tolerability of 3 Oral Formulations of Sodium Thiosulfate	NCT02624479	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2018-12-31	2019-12-31	2020-12-31	-	-	2025-07-14
Validation of High-resolution PET/CT for the Pretherapeutic Lymphnode Staging of Head/Neck Cancer	NCT02372890	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2012-07-31	2017-12-31	2018-12-31	-	-	2025-07-14
The Ocular Microbiome in Patients With Dry Eye Disease	NCT04656197	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2019-09-30	2020-03-04	2021-03-04	-	-	2025-07-14
Surgical Versus Non-Surgical Treatment of Thoracolumbar Burst Fracture	NCT05769114	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2023-04-18	2030-03-31	2031-03-31	-	-	2025-07-14
Assessment of Anatomic, Physiologic and Biomechanical Characteristics of the Anal Canal and Pelvic Floor. An Observational Pilot Study	NCT02263170	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2015-03-31	2015-11-30	2016-11-30	-	-	2025-07-14
Predicting Disease Activity and Rebound Risk in MS Patients Treated With Sphingosine-1-phosphate Receptor Modulators (S1PRM)	NCT05828901	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2023-03-27	2027-03-31	2028-03-31	-	-	2025-07-14
Suprafascial Vancomycin Powder for Prevention of Surgical Site Infections After Instrumented Posterior Spinal Fusion	NCT04017468	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2019-10-15	2027-03-31	2028-03-31	-	-	2025-07-14
Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease in Children With Cystic Fibrosis	NCT04026360	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2011-07-01	2050-12-31	2051-12-31	-	-	2025-07-14
Status Telemetry for Cochlear Implantations	NCT06223724	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2023-10-25	2024-10-01	2025-10-01	-	-	2025-07-14
Prophylactic Mesh Implantation in Patients With Peritonitis for the Prevention of Incisional Hernia	NCT01802164	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2013-03-31	2015-04-30	2016-04-30	-	-	2025-07-14
Fetal Monitoring by Transabdominal Electrocardiogram Recording	NCT04574739	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2020-07-01	2020-10-31	2021-10-31	-	-	2025-07-14
Artificial Intelligence (AI) in Cardiotocography (CTG) Interpretation	NCT04584281	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2020-10-31	2021-06-30	2022-06-30	-	-	2025-07-14
MRI-markers to Monitor Small Vessel Disease Dynamics in the Prognosis of Small Vessel Disease-associated, Cerebrovascular Events	NCT05773235	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2022-07-01	2024-06-30	2025-06-30	-	-	2025-07-14
Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment	NCT02068625	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2010-09-30	2018-12-31	2019-12-31	-	-	2025-07-14
Stress Response in Emergency Among Physicians in Helicopter and Ambulance Based Emergency Medical Systems	NCT03422952	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2017-04-30	2018-11-01	2019-11-01	-	-	2025-07-14
Bendamustine and Melphalan in Myeloma	NCT03187223	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2017-07-20	2020-05-28	2021-05-28	-	-	2025-07-14
ILMA Fastrach Versus I-gel for Fiberoptic Tracheal Intubation	NCT00888875	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2008-07-31	2010-05-31	2011-05-31	-	-	2025-07-14
Involvement of the Gut Microbiota in Calcified Aortic Stenosis	NCT06021535	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2024-01-01	2028-12-31	2029-12-31	-	-	2025-07-14
Renal Denervation in Patients With Recurrent Atrial Fibrillation After Successful Pulmonary Vein Isolation	NCT05817318	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2023-06-27	2026-12-31	2027-12-31	-	-	2025-07-14
Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis	NCT04874428	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2021-05-19	2026-06-30	2027-06-30	-	-	2025-07-14
Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients	NCT05636787	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2023-06-06	2028-04-30	2029-04-30	-	-	2025-07-14
Visual Field Defect Estimation Using Sequentially Optimized Reconstruction Strategy on Healthy and Glaucoma Subjects	NCT03325751	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2018-06-01	2019-11-01	2020-11-01	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance